{"id":"W3132433975","doi":"10.1016/j.cgh.2021.02.026","title":"Vedolizumab for the Treatment of Noninflammatory Bowel Disease Related Enteropathy","year":2021,"lang":"en","type":"review","venue":"Clinical Gastroenterology and Hepatology","topic":"Microscopic Colitis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary; Robarts Clinical Trials; Western University","funders":"","keywords":"Vedolizumab; Medicine; Addressin; Enteropathy; Ulcerative colitis; Inflammatory bowel disease; Gastroenterology; Crohn's disease; Internal medicine; Immunology; Disease; Integrin; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003734184,0.0006749028,0.001662266,0.001557083,0.0001894582,0.0006768713,0.0008090393,0.0006819756,0.003352722],"category_scores_gemma":[0.0005969236,0.0001799846,0.0006316518,0.001323196,0.0002856759,0.0005997911,0.000427098,0.001437765,0.0009859594],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003500957,"about_ca_system_score_gemma":0.0006085649,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001266371,"about_ca_topic_score_gemma":0.002993286,"domain_scores_codex":[0.9998814,0.00002406732,0.00002217116,0.00002187434,0.00003582015,0.00001456106],"domain_scores_gemma":[0.9997849,0.0001105318,0.00004485861,0.000004636839,0.00003564692,0.00001948147],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002008332,0.00006290477,0.0001233347,0.02404345,0.000257677,0.0001917045,0.00002532918,0.0002109385,0.001106588,0.0007767369,0.02116439,0.9518361],"study_design_scores_gemma":[0.0003984435,0.0004714217,0.002689948,0.01617525,0.001628141,0.00356084,0.00007404274,0.0002629616,0.0007925364,0.001533811,0.9723608,0.00005178653],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009695659,0.9993642,0.00004569426,0.00008054566,0.00009163398,0.000002957983,0.00001288727,0.000003815775,0.0003013096],"genre_scores_gemma":[0.001100651,0.9981446,0.000130941,0.0001803252,0.0001128768,0.000004864221,0.00003220177,0.000001107078,0.0002924168],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003352722,"threshold_uncertainty_score":0.01121598,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07865903264127785,"score_gpt":0.4190182107537824,"score_spread":0.3403591781125046,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}